Skip to content

Clinical trials

Dermatitis, Atopic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis, Atopic Country / region: South Korea Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20121
20132
20143
20154
20167
20173
201810
20198
20207
20215
20225
202311
202410
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Active, not recruiting11
Terminated9
Unknown status8
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kang Stem Biotech Co., Ltd.9
AbbVie7
Amgen7
Eli Lilly and Company7
Sanofi7
Pfizer6
Regeneron Pharmaceuticals5
Amorepacific Corporation3
EHL Bio Co., Ltd.3
LEO Pharma3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis, Atopic80
Eczema16
Dermatitis8
Skin Diseases6
Immune System Diseases3
Hypersensitivity2
Lymphoma, Follicular2
Arthritis, Psoriatic1
Arthritis, Rheumatoid1
Asthma1

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.